CD63 associates with CD11/CD18 in large detergent-resistant complexes after translocation to the cell surface in human neutrophils11Presented in part at the annual meetings of the American Society of Hematology, Miami, FL, 4–8 December 1998, and the American Society for Cell Biology, San Francisco, CA, 12–16 December 1998.  by Skubitz, Keith M. et al.
CD63 associates with CD11/CD18 in large detergent-resistant complexes
after translocation to the cell surface in human neutrophils1
Keith M. Skubitza;d;*, Kenneth D. Campbella;d, Amy P.N. Skubitzb;c
aDepartment of Medicine, The University of Minnesota Medical School, Minneapolis, MN 55455, USA
bDepartment of Laboratory Medicine and Pathology, The University of Minnesota Medical School, Minneapolis, MN 55455, USA
cBiomedical Engineering Center, The University of Minnesota Medical School, Minneapolis, MN 55455, USA
dMasonic Cancer Center, Minneapolis, MN 55455, USA
Received 12 December 1999; received in revised form 20 January 2000
Edited by Shmuel Shaltiel
Abstract CD63 antibody binding to the neutrophil surface
triggers a transient activation signal that regulates the adhesive
activity and surface expression of CD11/CD18. Gel permeation
chromatography demonstrated that all of the cell surface CD11/
CD18 associated with CD63 eluted in the void volume, indicating
that they were present in large detergent-resistant complexes. In
contrast, the majority of the total cellular CD63, CD11 and
CD18, which are largely intracellular, was not present in
complexes. The data suggest that intracellular CD11, CD18
and CD63 are not in detergent-resistant complexes, but enter
such complexes following translocation to the cell surface.
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1. Introduction
In neutrophils, CD63 is an activation antigen in that its
surface expression is upregulated from intracellular stores by
stimulation [1,2] and CD63 antibody binding to the neutrophil
surface triggers a transient activation signal that requires ex-
tracellular calcium and regulates the adhesive activity and sur-
face expression of CD11b/CD18 (the L2-integrin subfamily
member also known as HMac-1) [2]. CD63 has been found
in a wide variety of cells including neutrophils, platelets, ba-
sophils, cytotoxic T-lymphocytes and the Weibel^Palade
bodies of endothelial cells [1^6] CD63 is identical to the
ME491 antigen, originally described as a stage-speci¢c di¡er-
entiation antigen of melanoma cells [5^7] and to granulo-
physin, de¢cient in platelets, but not leukocytes, of patients
with the Hermansky^Pudlak syndrome [8]. CD63 is one of the
major lysosomal membrane proteins (LAMPs) [9,10].
CD63 is a member of the tetraspan family, traversing the
membrane four times and having a major extracellular loop
and a small extracellular loop, with short intracellular amino
and carboxy termini [3,5^10]. The major extracellular domain
is heavily glycosylated and contains poly-N-acetyllactosamines
[3,9,10]. The intracellular domains of CD63 are small and
have no clear motif known to be involved in signal transmis-
sion. The previous ¢nding of the association of CD11b/CD18
and protein kinase activity, including the src family kinases
lyn and hck, with CD63 [2] suggests that these associations
may be involved in signal transduction, but the nature of
these associations are unclear.
Recent studies have demonstrated the existence of large
non-covalent detergent-resistant complexes in cell extracts
that contain important signaling molecules, including protein
kinases and many glycosyl-phosphatidylinositol (GPI)-linked
membrane proteins capable of transmitting signals [11^19]. In
this study, gel ¢ltration chromatography demonstrated that
most of the cell surface CD11b/CD18 associated with CD63
was present in such complexes. In addition, most of the total
cell surface CD11b/CD18 was present in such complexes,
however, some was also detected in lower mobility fractions.
In contrast, most of the total cellular CD63, CD11b and
CD18, which are largely intracellular, was not present in these
complexes. Thus, CD11b/CD18 and CD63 appear to associate
and enter large detergent-resistant complexes following trans-
location to the cell surface. The colocalization of CD11b/
CD18 and CD63 in these complexes may play a role in signal
transmission by CD63.
2. Materials and methods
2.1. Antibodies and reagents
Normal mouse IgG and normal mouse serum (NMS) were pur-
chased from Sigma (St. Louis, MO). The CD63 mAb AHN-16 [2],
the CD45 mAb AHN-12 (IgG1) [20], and the CD11b mAb OKM1
(IgG2b) [21], have been previously described. The CD18 mAb 60.3
(IgG2a) was a gift of Dr. J. Harlan, University of Washington, Seat-
tle, WA.
2.2. Preparation of biotinylated cell extract and immunoprecipitation
Neutrophils were prepared from heparinized (2 U/ml) human
venous blood as described [22]. Neutrophils were biotinylated with
sulfosuccinimidyl-6-(biotinamido)hexanoate (Pierce, Rockford, IL),
treated with 10 mM diisopropyl£uorophosphate (DFP) (Sigma), solu-
bilized and used for immunoprecipitation as previously described
[2,23] or analyzed by SDS^PAGE directly. Biotinylated proteins,
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were visualized by using an enhanced chemiluminescence system after
transfer to Immobilon transfer membranes (Millipore Corp., Bedford,
MA) as previously described [2,24].
2.3. Gel chromatography
Gel ¢ltration chromatography was performed as previously de-
scribed [16]. Brie£y, 3 ml columns (0.8U5 cm) of Sepharose 4B (Phar-
macia) were equilibrated with Brij solubilization bu¡er at 4‡C and 0.3
ml of cell extract was applied to the top of the column. The column
was eluted with Brij solubilization bu¡er and 0.3 ml fractions were
collected. The column was calibrated with blue dextran (void volume)
(Sigma), which eluted in fractions 2 and 3, and IgG, which eluted in
fraction 7.
3. Results
3.1. Gel ¢ltration chromatography of biotin-labeled proteins
Recent reports suggest that some cell surface proteins may
exist in detergent-resistant complexes that can be resolved by
gel ¢ltration chromatography [11,15^19]. To determine if the
CD11b/CD18 associated with CD63 has similar properties,
neutrophils were surface-labeled with biotin, extracted with
Brij bu¡er and fractionated by gel permeation chromatogra-
phy on Sepharose 4B as described in Section 2. Aliquots of
each fraction were immunoprecipitated with the CD63 mAb
AHN-16 (Fig. 1, left panel). Since CD63 is not e⁄ciently
labeled with biotin under these conditions [2,25] only biotin-
labeled proteins associated with CD63 are visualized. Essen-
tially, all of the observed biotin-labeled protein associated
with CD63 is accounted for by CD11b/CD18 [2]. CD11b/
CD18 is readily detected in the void volume in column frac-
tions 2 and 3 (Fig. 1, lanes 2 and 3, left panel). At this level of
detection, no CD11b/CD18 was detected in fraction 1 (not
shown) or in fractions 4^8 (Fig. 1, lanes 4^8, left panel).
Most of the biotin-labeled CD11b/CD18 was present in frac-
tion 2 (in Fig. 1, 20% of the fraction 2 immunoprecipitate was
loaded in lane 2 while 100% of the corresponding immuno-
precipitates of fractions 3^8 were loaded on the gel). Biotin-
labeled CD11b/CD18 were not detected in immunoprecipi-
tates using NMS (right panel). Since the exclusion limit of
Sepharose 4B is more than V20 million Da, most cell-surface
CD11b/CD18 that is associated with CD63 appears to be
present in complexes of relatively large size.
Most neutrophil CD63 is present intracellularly, largely in
the primary granules [1]. Therefore, in light of the above re-
sults, it would be predicted that less biotin-labeled CD11b/
CD18 might be detected in a CD63 immunoprecipitate from
whole cell extract, since the signal would be diluted by CD63
from the primary granules. Indeed, at the level of detection
used in Fig. 1, very little biotin-labeled CD11b/CD18 was
detected in a CD63 immunoprecipitate from unfractionated
cell extract (labeled ‘E‘ in Fig. 1, left panel) compared with
that observed in the void volume in fraction 2 (lane 2) (in Fig.
1, 20% of the whole cell extract and fraction 2 immunopreci-
pitates were loaded on the gel in lanes E and 2, respectively).
As expected, no biotin-labeled CD11b/CD18 was detected in
immunoprecipitates using the control antibody NMS (Fig. 1,
right panel).
The distribution of cell-surface CD11b and CD18 in deter-
gent-resistant complexes in neutrophils was examined directly
by immunoprecipitation of biotin-labeled neutrophil extract
fractionated by gel permeation chromatography on Sepharose
4B (Figs. 2 and 3, respectively). CD11b, detected by immuno-
precipitation with the CD11b mAb, OKM1 and associated
CD18 were readily detected in the cell extract (Fig. 2, lane
E) and in fractions 2 and 3, but were also detected in fractions
Fig. 1. Distribution of the CD63-CD11b/CD18 complexes in gel permeation chromatography fractionated neutrophil extract. Neutrophils were
surface-labeled with biotin, solubilized in Brij solubilization bu¡er, and the extract was fractionated by gel permeation chromatography on Se-
pharose 4B as described in Section 2. Column fractions were immunoprecipitated with the CD63 mAb AHN-16 (left panel) or NMS (right pan-
el), analyzed by SDS^PAGE under reducing conditions, and the surface-labeled proteins detected as described in Section 2. Lane 1 contains an
immunoprecipitate from whole cell extract (E). The column fractions are indicated by the numbers at the top of the gels. Lanes E and 2 were
loaded with 20% of their respective immunoprecipitates while 100% of the immunoprecipitates of fractions 3^8 were applied to their respective
lanes. The arrows indicate the positions of the V165-kDa CD11b and the V100-kDa CD18. Blue dextran eluted in fractions 2 and 3 (void
volume), while IgG eluted in fraction 7. A duplicate experiment gave similar results. Proteins used as molecular weight standards were: myosin
heavy chain, 200 000; Escherichia coli L-galactosidase, 116 000; phosphorylase a, 97 400; bovine serum albumin, 66 000; ovalbumin, 45 000; and
carbonic anhydrase, 29 000.
FEBS 23383 29-2-00
K.M. Skubitz et al./FEBS Letters 469 (2000) 52^56 53
4^6 (Fig. 2, lanes 2^6). Similarly, immunoprecipitation with
the CD18 mAb 60.3, readily detected CD11b and CD18 in the
cell extract (Fig. 3, lane E) and in fractions 2 and 3 (Fig. 3,
lanes 2^3). However, some CD11b and CD18 were also de-
tected in fractions 4^6 (Fig. 3, lanes 4^6). As in Fig. 1, 20% of
the whole cell extract immunoprecipitate and the fraction 2
immunoprecipitate and 100% of the immunoprecipitates of
fractions 3^8, were loaded on the gel in Figs. 2 and 3. NMS
did not immunoprecipitate any biotin-labeled protein (Fig. 1,
right panel).
Since some CD45 mAbs have been reported to inhibit neu-
trophil chemotaxis [20], column fractions were also analyzed
by immunoprecipitation with the CD45 mAb AHN-12. All
detectable biotin-labeled CD45 was present in the void vol-
ume, i.e. fractions 2 and 3 (Fig. 4). No other biotinylated
proteins were detectable in the CD45 immunoprecipitates.
3.2. Gel permeation chromatography of total cell CD11b,
CD18 and CD63
Since most CD11b/CD18 is present intracellularly in sec-
ondary granules [26] we examined the distribution of total
neutrophil CD18 in detergent-resistant complexes by fractio-
nating a neutrophil extract by gel permeation chromatogra-
phy on Sepharose 4B, and analyzing the fractions by SDS^
PAGE and immunoblotting with the CD18 mAb 60.3 (Fig. 5).
In contrast to the fractionation of cell-surface CD18 detected
by biotin-labeling intact neutrophils, total cellular CD18 ap-
peared to be evenly distributed among fractions 2^7 and could
also be faintly detected in fractions 8 and 9 (Fig. 5, top panel).
CD18 was not seen in parallel experiments when immunoblot-
ting was conducted using NMS as the control antibody (Fig.
5, bottom panel).
Fig. 2. Distribution of cell-surface CD11b in gel permeation chro-
matography fractionated neutrophil extract. Column fractions were
immunoprecipitated with the CD11b mAb OKM1 and analyzed as
in Fig. 1. The arrows indicates the position of CD11b and CD18.
Fig. 3. Distribution of the cell-surface CD18 in gel permeation chro-
matography fractionated neutrophil extract. Column fractions were
immunoprecipitated with the CD18 mAb 60.3 and analyzed as in
Fig. 1. The arrows indicates the positions of CD11b and CD18.
Fig. 4. Distribution of the cell-surface CD45 in gel permeation chro-
matography fractionated neutrophil extract. Column fractions were
immunoprecipitated with the CD45 mAb AHN-12 and analyzed as
in Fig. 1. 100% of the immunoprecipitates were applied to their re-
spective lanes. The arrow indicates the position of CD45.
Fig. 5. Distribution of the total cell CD18 in gel permeation chro-
matography fractionated neutrophil extract. Neutrophils were solu-
bilized in Brij solubilization bu¡er, and the extract was fractionated
as in Fig. 1, separated by SDS^PAGE under reducing conditions,
transferred to Immobilon-P, and CD18 was detected by immuno-
blotting with the CD18 mAb 60.3 (top panel). NMS was used as a
control antibody for immunoblotting (bottom panel). The arrow in-
dicates the position of CD18.
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The distribution of total neutrophil CD63 in complexes was
also examined by gel permeation chromatography and immu-
noblotting with the CD63 mAb AHN-16. As observed with
CD18, total cellular CD63, which appears routinely as a
broad band over a wide range of apparent molecular weight
due to extensive and variable glycosylation, appeared to be
rather evenly distributed among fractions 2^7 (Fig. 6, left
panel). This band of V30^100 kDa was not seen in parallel
experiments when immunoblotting was conducted using NMS
as the control antibody (Fig. 6, right panel).
4. Discussion
In this study, gel ¢ltration of neutrophils solubilized in Brij
58 demonstrated that the cell-surface CD11b/CD18 associated
with CD63 was found in large detergent-resistant complexes.
In addition, the majority (but not all) of the total cell-surface
CD11b/CD18 in neutrophils was also present in such com-
plexes. In contrast, the majority of total cellular CD11b/
CD18 was not restricted to these complexes. Similarly, the
majority of total neutrophil CD63 was not present in such
complexes. Thus, the data suggest that in neutrophils, CD63
and CD11b/CD18 are not present in large detergent-resistant
complexes while intracellular, but become sequestered in
membrane domains corresponding to such complexes follow-
ing translocation to the cell surface.
Several studies have described the existence of very large
non-covalent complexes relatively resistant to dissociation by
detergent [11^19]. It has been postulated that these complexes
re£ect the existence of speci¢c membrane microdomains that
have a particular lipid composition and these clusters may be
important in the transmembrane signaling by proteins in the
complex [11^14,18]. Studies of the subcellular distribution of
glycosphingolipids in neutrophils have found no major di¡er-
ences among the primary granules, secondary granules and
plasma membranes, in the relative amounts of the ¢ve major
neutrophil glycosphingolipids. However, relatively more K-
2,3-sialosylneolactotetraosyl-ceramide may be present in the
plasma membrane than in the primary and secondary gran-
ules [27].
Previous studies demonstrated that the binding of CD63
mAbs to the neutrophil surface results in a transient activa-
tion state during which time a signal can be transmitted to
CD11b/CD18 if extracellular calcium is present, resulting in
an increase in CD11b/CD18 adhesive activity and surface ex-
pression [2]. The CD11b/CD18 complex is well known to play
an important role in neutrophil adhesion (reviewed in [2,28]).
Thus, CD63 plays a signaling role and regulates the adhesion
activity of CD11b/CD18 in human neutrophils and may play
an important regulatory role in in£ammation via its e¡ects on
leukocyte function. CD63 has been reported to associate with
CD11b/CD18 in neutrophils [2] and K3L1 and K6L1 integrins
in several cell lines [25,29,30]. However, this is the ¢rst report
of the tetraspan CD63 localizing in large detergent-resistant
complexes and the ¢rst demonstration of such complexes in
neutrophils.
The urokinase plasminogen activator receptor in monocytes
has been found to be present in a large receptor complex
containing CD18 (L2 integrin) and the src kinases fyn, lyn,
hck and fgr [16]. A recent report suggests that most of the
cell-surface L1 integrin in ovarian carcinoma cells is present as
large detergent-resistant complexes [31].
Data suggest that more than one type of large complex
containing di¡erent GPI-anchored proteins exist in monocytes
[16] and thymoma cells [32]. We found that most neutrophil
cell-surface CD45 was also present in such complexes, but not
associated with CD63 or CD11b/CD18, thus demonstrating
the existence of more than one type of large detergent-resist-
ant complex in neutrophils.
Thus, the present study demonstrates that CD11b/CD18
associated with the tetraspan CD63 on the neutrophil surface
is present in large detergent-resistant complexes. This associ-
ation, and entry into large detergent-resistant complexes, oc-
curs after translocation to the cell surface, since most intra-
cellular CD11b, CD18 and CD63 are not present in such
complexes. Also, CD63 resides in a di¡erent intracellular
granule population than CD11b/CD18. In addition, the ma-
jority of cell-surface CD11b and CD18, as identi¢ed by biotin
labeling, was also present in large detergent-resistant com-
plexes. The sequestration of signal transducing and e¡ector
molecules in complexes in membrane microdomains may
play a role in signal transduction and e¡ector function by
Fig. 6. Distribution of the total cell CD63 in gel permeation chromatography fractionated neutrophil extract. Neutrophils were solubilized in
Brij solubilization bu¡er, and the extract was fractionated as in Fig. 1, and analyzed by SDS^PAGE under non-reducing conditions, transferred
to Immobilon-P, and CD63 was detected by immunoblotting with the CD63 mAb AHN-16 (left panel). NMS was used as a control antibody
for immunoblotting (right panel).
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increasing the local concentration of reactive species, thus
leading to potential cooperativity or other mechanisms.
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